Giuliari G.P.,Central University of Venezuela |
Giuliari G.P.,Altamira |
Sadaka A.,Trihealths Good Samaritan Hospital |
Hinkle D.M.,Albany Retina Consultants PLLC
International Ophthalmology | Year: 2014
Experimental uveitis models were developed in an effort to elucidate the pathogenesis of human uveitis. The therapeutic effects of numerous anti-inflammatory agents including corticosteroids and immunomodulatory agents including biologic response modifiers have been investigated in both experimental and human uveitis. Monoclonal antibodies to tumor necrosis factor alpha and anti-interleukins, among others, demonstrate efficacy and are employed in the treatment of uveitis refractory to conventional immunomodulatory agents. © 2013 Springer Science+Business Media.